Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00227955 · ClinicalTrials.gov registry record · Phase 4

Comparing Various Treatments for Achieving and Maintaining Remission of Depression

A Phase 4 study, sponsored by University of Pittsburgh.

Completed
Registry status
Phase 4
Development phase
200
Enrollment target

NCT00227955 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 200 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00227955, a Phase 4 study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
Phase 4
Development phase
200 participants
Enrollment target

Study Summary

This study will evaluate the effectiveness of five combinations of drug therapy and psychotherapy in maintaining remission of depression symptoms in people with recurrent major depression.

Interventions

  • BEHAVIORAL Interpersonal Psychotherapy
  • DRUG Imipramine

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 1987-12
Est. Completion 1993-12
Phase Phase 4

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT00227955

The ClinicalTrials.gov registry entry for NCT00227955 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Interpersonal Psychotherapy is the first listed.

NCT00227955 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00227955 about?

NCT00227955 is a clinical study titled "Comparing Various Treatments for Achieving and Maintaining Remission of Depression". This study will evaluate the effectiveness of five combinations of drug therapy and psychotherapy in maintaining remission of depression symptoms in people with recurrent major depression.

What is the current status of trial NCT00227955?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 1987-12. Estimated completion is 1993-12.

What interventions are being tested in trial NCT00227955?

The interventions under investigation include: Interpersonal Psychotherapy (BEHAVIORAL), Imipramine (DRUG).

Who is sponsoring clinical trial NCT00227955?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.